A study on microvascular abnormalities in capillaroscopy in patients with type 1 diabetes mellitus

Diabetologia Doswiadczalna i Kliniczna

Volumn 6, Issue 2, 2006, Pages 98-103

  Kuryliszyn Moskal, Anna ^a,b   Zarzycki, Wiesław ^a   Dubicki, Artur ^a   Zonenberg, Anna ^a   Górska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Klinika Endokrynologii   (Poland)

Author keywords

Capillaroscopy; Diabetes type 1; Metabolic control; Microangiopathy

Indexed keywords

ADULT; ARTICLE; BODY MASS; CAPILLAROSCOPY; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE DURATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC REGULATION; STATISTICAL ANALYSIS;

EID: 33744826809     PISSN: 16433165     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Grassi W, Del Medico P. Atlante di Capillaroscopia. EDRA, Milano 2004.
2. Cutolo M, Sulli A, Pizzorni C, Accardo S. Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol 2000; 27: 155-160.
3. Kuryliszyn-Moskal A. Waskulopatia w przebiegu reumatoidalnego zapalenia stawów. Studium kliniczno-immunologiczne w aspekcie zmian morfologicznych w badaniu kapilaroskopowym. Akademia Medyczna w Białymstoku, Białystok 1996.
4. Ubbink DTh, Verhaar EE, Lie HKI, Legemate DA. Effect of β-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease. J Vasc Surg 2003; 38: 535-540.
5. European Diabetes Policy Group Podrȩczny poradnik postȩpowania w cukrzycy typu 1 (insulinozaleznej). Med Prakt 1998; suppl 1.
6. Zalecenia kliniczne dotycza̧ce postȩpowania u chorych na cukrzycȩ, 2005. Diabetologia Dośw Klin 2004 (suppl E): E1-E42.
7. Colwell JA, Halushka PV, Sarji KE, Lopez-Virella MF, Sagel J. Vascular disease in diabetes. Pathophysiological mechanisms and therapy. Arch Intern Med 1979; 139: 225-230.
8. Harris MI, Modan M. Screening for NIDDM. Why is there no national program. Diabetes Care 1994; 17: 440-444.
9. Tatoń J. Zmiany narza̧du wzroku w przebiegu cukrzycy. W: Powikłania cukrzycy. PZWL, 1995: 48-91.
10. Choy G, Kali-Rai R. Diabetic long-term complications. Calif Pharmac 1994; 8: 33-41.
11. Perkins AT, Morgenlander JC. Endocrinologic causes of peripheral neuropathy. Postgraduate Medicine 1997; 102: 81-106.
12. Bollinger A, Fagrell B. Clinical Capillaroscopy. Hogrefe & Huber Publishers, Toronto 1990.
13. Gasser P, Berger W. Nailfold videomicroscopy and local cold test in type 1-diabetes. Angiology 1992; 43: 395-400.
14. Meyer MF, Pfohl M, Schatz H. Nachweis diabetischer mikrozirkulationsveränderungen mittels kapillaroskopie und laser-doppler-anemometrie. Med Klin 2001; 96: 71-77.
15. Brownlee J, Cerami A, Vlassara H. Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1998; 318: 1315-1321.
16. Wiedermann P. Wie entsteht die diabetische retinopathie? Ophthalmologe 1993; 90: 426-433.
17. Zaugg-Vesti BR, Franzeck UK, von Ziegler C et al. Skin capillary aneurysms detected by indocyanine green in type I diabetes with and without retinal microaneurysms. Int J Microcirc 1995; 15: 193-198.
18. Meyer MF, Pfohl M, Schatz H. Correlations between morphological and functional microcirculatory alterations in diabetes and the impact of metabolic control and disease duration. Microvasc Res 2000; 59: 186-189.
19. Forst T, Pfutzner A, Kunt T et al. Skin microcirculation in patients with type I diabetes with and without neuropathy after neurovascular stimulation. Clin Sci 1998; 94: 255-261.
20. Fagrell B, Hermansson IL, Karlander SG, Östergren J. Vital capillary microscopy for assessment of skin viability and microangiopathy in patients with diabetes mellitus. Acta Med Scand 1984 (suppl 687): 25-28.